SpicyIP (spicyip.bsky.social) (@SpicyIP) header
SpicyIP (spicyip.bsky.social) (@SpicyIP) profile picture

We aim to foster a more transparent, collaborative and productive IP/innovation eco-system for India. Retweets are not endorsements.

India
Joined March 2011
Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)Photo by SpicyIP (spicyip.bsky.social) (@SpicyIP)
Can Bangladesh’s deferred LDC graduation help keep life-saving medicines affordable in India? In this post, Maneesha Gupta traces the link between Bangladesh’s TRIPS pharmaceutical exemption... (1/2)
1
1
1
168
SpicyIP (spicyip.bsky.social) retweeted
The DHC's recent approach to territorial jurisdiction in IP disputes marks a welcome shift from its traditionally expansive approach to entertaining IP suits. Building on Justice Kaurav’s ruling in ABD Maestro,...(1/2)
1
2
1
13
1,563
In Part I, Dr. Aakanksha Kumar argued that the MHC's order in Saravanan Hari v. Blink Commerce reached the right result without sorting out the claims it was enforcing, and that the plaintiff’s celebrity status is beside the point. Part II looks at the persona...(1/2)
1
1
2
299
A CSK superfan who paints himself yellow and writes Dhoni’s (nick)name and number on his body has won an interim injunction against Blinkit in the Madras High Court. In Part I of this post, Dr. Aakanksha Kumar looks at what the order gets right, where it once again... (1/2)
1
3
401
The Patent Office’s rejection of TB Alliance’s patent application for the BPaL tuberculosis drug regimen has been widely welcomed as a win for access to medicines. However, the rather brief rejection order raises some important questions about the quality of reasoning... (1/2)
1
1
2
250
The DHC's recent approach to territorial jurisdiction in IP disputes marks a welcome shift from its traditionally expansive approach to entertaining IP suits. Building on Justice Kaurav’s ruling in ABD Maestro,...(1/2)
1
2
1
13
1,563
Priced at Rs. 2.66 crore, Trikafta remains out of reach for most patients with Cystic Fibrosis in India. Despite repeated appeals by patients and the availability of several safeguards under the Patents Act to address such situations, little has changed. (1/2)
2
3
2
224
This week’s Bell of the Week: Public Lab This week, we look at Public Lab, a community-led initiative that emerged in the aftermath of the Deepwater Horizon oil spill. Through open-source tools, shared research and collaborative documentation, (1/3)
1
142
Public Lab showed how environmental science could become more accessible and participatory. It also offers an interesting perspective on intellectual property: how open licences and shared knowledge can enable people to create, adapt and build upon one another's work. (2/3)
1
33
SpicyIP Weekly Review (November 09-November 15) After a busy week featuring several interesting and important posts on some pressing questions in Indian IP law and policy, we are back to kick off the week with another edition of the SpicyIP Weekly Review. (1/3)
1
134
This Weekly Review brings together discussions on a range of issues, from the proposed introduction of data exclusivity and its implications for India’s pharmaceutical landscape to the limits of territorial jurisdiction in IP disputes...(2/3)
1
38